Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Beyond Air, Inc. Director's Dealing 2024

Nov 27, 2024

35161_dirs_2024-11-26_8dae2a2b-b00b-4581-9658-87b8cb60b30f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Beyond Air, Inc. (XAIR)
CIK: 0001641631
Period of Report: 2024-11-22

Reporting Person: Lisi Steven A. (Director, CEO and Chairman of the Board)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-11-22 Stock Options (Right to buy) $1.53 D 950000 Disposed Common Stock (950000) Direct
2024-11-22 Stock Options (Right to buy) $0.54 A 950000 Acquired Common Stock (950000) Direct
2024-11-22 Stock Options (Right to buy) $6.28 D 800000 Disposed Common Stock (800000) Direct
2024-11-22 Stock Options (Right to buy) $0.54 A 800000 Acquired Common Stock (800000) Direct
2024-11-22 Stock Options (Right to buy) $6.87 D 280000 Disposed Common Stock (280000) Direct
2024-11-22 Stock Options (Right to buy) $0.54 A 280000 Acquired Common Stock (280000) Direct
2024-11-22 Stock Options (Right to buy) $5.45 D 200000 Disposed Common Stock (200000) Direct
2024-11-22 Stock Options (Right to buy) $0.54 A 200000 Acquired Common Stock (200000) Direct
2024-11-22 Stock Options (Right to buy) $5.32 D 70000 Disposed Common Stock (70000) Direct
2024-11-22 Stock Options (Right to buy) $0.54 A 70000 Acquired Common Stock (70000) Direct
2024-11-22 Stock Options (Right to buy) $4.80 D 250000 Disposed Common Stock (250000) Direct
2024-11-22 Stock Options (Right to buy) $0.54 A 250000 Acquired Common Stock (250000) Direct
2024-11-22 Stock Options (Right to buy) $4.25 D 400000 Disposed Common Stock (400000) Direct
2024-11-22 Stock Options (Right to buy) $0.54 A 400000 Acquired Common Stock (400000) Direct

Footnotes

F1: On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the "Effective Date") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged.

F2: This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date.